(Q44640299)

4 December 2017

title

Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid β-peptide (English)

1 reference

4 December 2017

1 reference

1 reference

12

1 reference

4 December 2017

10

Philip Scheltens

1 reference

4 December 2017

2

Jeroen J M Hoozemans

1 reference

4 December 2017

Annemieke J M Rozemuller

11

object named as

Annemieke J M Rozemuller

1 reference

4 December 2017

3

Carsten Korth

1 reference

4 December 2017

13

Robert Veerhuis

1 reference

4 December 2017

7

Harry A M Twaalfhoven

1 reference

4 December 2017

1

Nicolaas A Verwey

1 reference

4 December 2017

6

Dorine Wouters

1 reference

4 December 2017

Marloes R van Royen

4

1 reference

4 December 2017

Ingrid Prikulis

5

1 reference

4 December 2017

Elise S van Haastert

8

1 reference

4 December 2017

Dale Schenk

9

1 reference

4 December 2017

language of work or name

1 reference

5 July 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

20

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

179-187

1 reference

Neuropathological stageing of Alzheimer-related changes

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Apolipoprotein J and Alzheimer's amyloid beta solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Clusterin (apoJ) Alters the Aggregation of Amyloid β-Peptide (Aβ1-42) and Forms Slowly Sedimenting Aβ Complexes That Cause Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Amyloid P component. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Amyloid associated proteins in Alzheimer's and prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Two types of sporadic cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Brain parenchymal and microvascular amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

The incidence of cerebral amyloid angiopathy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Structural characterization of a soluble amyloid beta-peptide oligomer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

The Global Deterioration Scale for assessment of primary degenerative dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2013.797389

10.3109/13506129.2013.797389

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference